In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent.
Between April 2002 and May 2004, 174 consecutive patients who underwent percutaneous coronary intervention of bifurcational lesions with sirolimus-eluting stents were identified. Two strategies were used: stenting only 1 branch (group 1S, n = 57) or stenting both branches (group 2S, n = 117). The incidence of major adverse cardiac events was evaluated in the hospital and at 9-month follow-up. There were no statistically significant differences between the 2 groups with regard to the incidence of target lesion revascularization (5.4% vs 8.9%, p = 0.76), target vessel revascularization (5.4% vs 11.1%, p = 0.51), and cumulative major adverse cardiac events (18.9% vs 23.3%, p = 0.76) at 9 months.
Ge
Lei
L
EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Tsagalou
Eleutheria
E
Iakovou
Ioannis
I
Sangiorgi
Giuseppe M
GM
Corvaja
Nicola
N
Airoldi
Flavio
F
Chieffo
Alaide
A
Montorfano
Matteo
M
Michev
Iassen
I
Colombo
Antonio
A
D000368:Aged; D000789:Angina, Unstable / Q000401:mortality / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000401:mortality / Q000628:therapy*; D023903:Coronary Restenosis / Q000401:mortality; D016757:Death, Sudden, Cardiac / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy; D010043:Outcome and Process Assessment, Health Care; D012307:Risk Factors; D020123:Sirolimus / Q000009:adverse effects*; D015607:Stents
D020123:Sirolimus